We are live on ! Find out more
WVP

Worth Venture Partners Portfolio holdings

AUM $31.6M
1-Year Est. Return 28.5%
This Fund
S&P 500
This Quarter Est. Return
+1.67%
1 Year Est. Return
+28.5%
3 Year Est. Return
+102.5%
5 Year Est. Return
+128.77%
10 Year Est. Return
–
AUM
$163M
AUM Growth
-$6.83M
Cap. Flow
-$37.1M
Cap. Flow %
-22.75%
Top 10 Hldgs %
30.94%
Holding
192
New
47
Increased
35
Reduced
23
Closed
17

Top Buys

Rank Stock Value
1
ADTN icon
Adtran
ADTN
+$6.46M
2
INDI icon
indie Semiconductor
INDI
+$2.74M
3
SILC icon
Silicom
SILC
+$2.7M
4
SEV
Sono Group N.V. Common Shares
SEV
+$2.6M
5
TELA icon
TELA Bio
TELA
+$2.22M

Top Sells

Rank Stock Value
1
CYBE
Cyberoptics Corp
CYBE
+$3.74M
2
CTO
CTO Realty Growth
CTO
+$865K
3
SCPH
scPharmaceuticals
SCPH
+$788K
4
ATEN icon
A10 Networks
ATEN
+$680K
5
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$640K

Sector Composition

Rank Sector Weight
1 Technology 23.41%
2 Healthcare 15.13%
3 Consumer Discretionary 5.61%
4 Financials 5.45%
5 Materials 2.94%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMBI
126
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$14K 0.01%
22,500
+2,500
+13% +$2.96K
BCS icon
127
PUT
Barclays
BCS
$94.9B
$13K 0.01%
27,000
– –
ABBV icon
128
CALL
AbbVie
ABBV
$432B
$10K 0.01%
+26,700
New +$3.83M
AXSM icon
129
PUT
Axsome Therapeutics
AXSM
$10.9B
$9K 0.01%
13,400
-50,300
-79% -$2.51M
MRNA icon
130
PUT
Moderna
MRNA
$22.5B
$9K 0.01%
+13,400
New +$2.03M
HZNP
131
PUT
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$9K 0.01%
+16,800
New +$1.17M
ICPT
132
CALL
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$8K ﹤0.01%
93,700
+45,900
+96% +$739K
AVXL icon
133
PUT
Anavex Life Sciences
AVXL
$287M
$7K ﹤0.01%
+13,400
New +$141K
ISEE
134
PUT
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$7K ﹤0.01%
+26,800
New +$352K
BMRN icon
135
PUT
BioMarin Pharmaceuticals
BMRN
$11.6B
$5K ﹤0.01%
+14,200
New +$1.26M
IMAX icon
136
PUT
IMAX
IMAX
$2.8B
$5K ﹤0.01%
+10,400
New +$167K
NTRA icon
137
PUT
Natera
NTRA
$38.8B
$5K ﹤0.01%
10,100
– –
FSR
138
PUT
DELISTED
Fisker Inc.
FSR
$5K ﹤0.01%
10,300
– –
CLNN icon
139
PUT
Clene
CLNN
$67M
$4K ﹤0.01%
+2,005
New +$133K
ATCO
140
PUT
DELISTED
Atlas Corp.
ATCO
$4K ﹤0.01%
+12,500
New +$163K
PRBM.WS
141
DELISTED
Parabellum Acquisition Corp. Redeemable Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
PRBM.WS
$3K ﹤0.01%
139,072
– –
BTU icon
142
PUT
Peabody Energy
BTU
$2.69B
$2K ﹤0.01%
19,800
– –
ADC icon
143
Agree Realty
ADC
$9.46B
– –
-3,223
Closed -$246K
ATEN icon
144
A10 Networks
ATEN
$2.27B
– –
-49,402
Closed -$680K
BLIN icon
145
Bridgeline Digital
BLIN
$14.9M
– –
-15,426
Closed -$22K
BW icon
146
Babcock & Wilcox
BW
$1.5B
– –
-30,616
Closed -$211K
DCBO
147
Docebo
DCBO
$531M
– –
-16,412
Closed -$456K
EPRT icon
148
Essential Properties Realty Trust
EPRT
$6.62B
– –
-12,438
Closed -$283K
ESS icon
149
Essex Property Trust
ESS
$18.3B
– –
-1,032
Closed -$275K
JBGS
150
JBG SMITH
JBGS
$666M
– –
-8,900
Closed -$221K
3 4 5
6
7

Similar funds

VL
Vorpal LLC Nashville, Tennessee $32M AUM 10.89% 1-Year Est. Return
SP
SCF Partners Houston, Texas $32.2M AUM 191.71% 1-Year Est. Return
OGC
One68 Global Capital New York $30.9M AUM
PE
Platinum Equity Beverly Hills, California $32.3M AUM 17.64% 1-Year Est. Return
RL
RPO LLC Stamford, Connecticut $32.3M AUM 14.17% 1-Year Est. Return
AIIC
AJU IB Investment Company Seoul, South Korea $30.5M AUM 128.96% 1-Year Est. Return
LGM
Lykos Global Management Stamford, Connecticut $30.4M AUM
SCA
SMH Capital Advisors Fort Worth, Texas $32.9M AUM 1.53% 1-Year Est. Return

Worth Venture Partners's Q3 2022 Portfolio in Review

As of Q3 2022, Worth Venture Partners held 192 positions worth $163M, down 4% from $170M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Worth Venture Partners withdrew a net $37.1M in Q3 2022, closing 17 positions and reducing 23 holdings. Its most notable exit was Cyberoptics Corp, an estimated $3.74M position sold in full.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 17% a quarter earlier, followed by Healthcare and Consumer Discretionary.

Against the trend, Worth Venture Partners opened a new position in Adtran worth $5.8M.

  • Worth Venture Partners's largest Q3 2022 buy was Adtran: 296,241 shares worth $5.8M.
  • Worth Venture Partners added most to TELA Bio in Q3 2022, an estimated $2.22M increase.
  • Worth Venture Partners's biggest Q3 2022 reduction was CTO Realty Growth, cutting an estimated $865K.
  • Worth Venture Partners fully exited Cyberoptics Corp in Q3 2022, selling an estimated $3.74M.
  • Worth Venture Partners's ten largest holdings make up 31% of its $163M portfolio in Q3 2022.
  • Worth Venture Partners opened 47 new positions and closed 17 in Q3 2022.
  • Worth Venture Partners's portfolio value fell 4% quarter-over-quarter to $163M.

Based on Worth Venture Partners's 13F filing for Q3 2022, filed 14 Nov 2022.